Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Achillion Pharmaceuticals Inc (NASDAQ:ACHN)

4.34
Delayed Data
As of Dec 09
 +0.11 / +2.60%
Today’s Change
3.78
Today|||52-Week Range
10.95
-59.78%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 4
2015
Quarter 1
2016
Quarter 2
2016
Quarter 3
2016
Revenue and IncomeNet Revenues31.6M0.000.000.00
 
 
Depreciation And Amortization189.0K192.0K240.0K258.0K
 
 
 
 
 
 
Operating ExpensesGross Income---192.0K-240.0K-258.0K
 
 
 
 
General Expenses15.0M18.6M19.1M21.6M
 
 
 
 
 
Other Operating Expenses0.000.000.00-258.0K
 
 
Research And Development9.8M13.3M14.2M16.8M
 
 
 
 
 
Total Operating Expenses15.2M18.8M19.4M21.6M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income16.4M-18.8M-19.4M-21.6M
 
 
 
 
 
Interest Expense On Debt13.0K15.0K12.0K27.0K
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income16.8M-18.1M-18.6M-20.8M
 
 
 
 
 
Income Taxes-140.0K-65.0K-60.0K-71.0K
 
 
 
 
 
Net Income17.0M-18.1M-18.5M-20.7M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS136.6M136.6M136.7M136.7M
 
 
 
 
 
Shares To Calculate EPS Diluted136.6M136.6M136.7M136.7M
 
 
 
 
 
 
Earnings Per ShareEPS$0.14-$0.13-$0.14-$0.15
 
 
 
 
 
EPS Diluted$0.12-$0.13-$0.14-$0.15